Public Company News

Kin + Carta supercharges growth with latest global acquisitions

LONDON, Feb. 22, 2022 /PRNewswire/ -- Global digital transformation consultancy Kin + Carta has agreed to acquire Bulgarian software development company Melon Group and its subsidiaries, includingMelon Technologies and Frakton LLC

2022-02-22 15:05 8241

Gaotu Techedu Announces Third Quarter of 2021 Unaudited Financial Results

BEIJING, Feb. 22, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the third quarter endedSeptember 30, 2021. In Jul...

2022-02-22 14:04 5379

Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

BEIJING, Feb. 22, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced that it will report its financial results for the fourth quarter and fiscal year ended...

2022-02-22 14:00 3828

BEST Inc. Announces Changes to its Board of Directors

HANGZHOU, China, Feb. 22, 2022 /PRNewswire/ -- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"), a leading integrated smart supply chain solutions and logistics services provider inChina, today announced that Mr. Jun Chen has resigned from his position as a director of the Company, effectiveFebru...

2022-02-22 14:00 2759

SOHU.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 UNAUDITED FINANCIAL RESULTS

BEIJING, Feb. 22, 2022 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video, and game business group, today reported unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2021. Fourth Quarter Highlights * Total revenues were US$1...

2022-02-22 13:00 3907

Winner Silver Alginate Dressing has Obtained 510K Code in the USA

SHENZHEN, China, Feb. 21, 2022 /PRNewswire/ -- Recently, the silver alginate dressing of Winner Medical (300888.SZ) receives U.S. FDA market access (510K Number: K202982), marking that this product has obtained the qualification to get into the access US market and Winner Medical will further e...

2022-02-22 10:10 2598

HONEYWELL SURVEY: 100% OF SOUTHEAST ASIA OFFICE WORKERS PLACE IMPORTANCE ON BEING INFORMED OF THEIR BUILDING'S AIR QUALITY

SINGAPORE and KUALA LUMPUR, Malaysia and MANILA, Philippines, Feb. 22, 2022 /PRNewswire/ -- In a survey of office workers inSoutheast Asia, all (100%) respondents working in an office building report it is important for their employer or building manager to keep them informed of their facility...

2022-02-22 10:00 5672

TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2021

BEIJING, Feb. 21, 2022 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the third quarter of fiscal year 2022 ended November 30, 2021.   Highlights for the Third Quarter of Fi...

2022-02-22 07:00 4265

Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development

* Recorded operating profit KRW 88.9 billion and net profit KRW 31.6 billion in 2021 with the outcome of its relentless focus on R&D * Attributed to export upswing of Nabota, KRW 1.1 trillion overseas technology transfer of Fexuclue tablets, and growth of highly profitable ETC drugs SEOUL, So...

2022-02-21 22:00 2753

HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer

SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofAlmira Chabi, M.D. as Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International (HPI), a U.S. entity wholly owned by HanAll Biopharma, to strengt...

2022-02-21 22:00 2580

Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2)in Frontiers in Immunology

NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 21, 2022 /PRNewswire/ -- recently -- Adlai Nortye Ltd. ("Adlai Nortye"), a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced the publication of preclinical research of AN3025 (anti-hTNFR2)...

2022-02-21 21:00 2538

Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that China National Medical Products Administration (NMPA) had approved its investigational new drug (IND) application for HBM9378 (or SKB378 as referred to ...

2022-02-21 20:29 2641

LAIX Inc. Announces Plan to Implement ADS Ratio Change

SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE: LAIX), an artificial intelligence (AI) company inChina that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Sh...

2022-02-21 20:00 4852

Puxin Limited Announces Regain Compliance with NYSE Minimum Price Requirement

BEIJING, Feb. 21, 2022 /PRNewswire/ -- Puxin Limited (NYSE: NEW) ("Puxin" or the "Company"), a private educational services provider inChina, today announced that based on a notification letter it received onFebruary 18, 2022 from the New York Stock Exchange ("NYSE"), the Company has regained com...

2022-02-21 19:03 4523

Weibo Corporation to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 3, 2022

BEIJING, Feb. 21, 2022 /PRNewswire/ -- Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the fourth quarter and fiscal year 2021 before the U.S. market opens onThursday, March 3...

2022-02-21 18:30 4360

XCMG Pushes for Carbon Neutrality within Its Operating Boundaries by 2049

SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- XCMG (SHE:000425) releases a program of action (PoA) for peak carbon and carbon neutrality, detailing planning, implementation and actual safeguard measures of sustainable transformation paths — including low-carbon transformation of energy consumption stru...

2022-02-21 17:23 2931

EP&T Global Secures New Multi-Year Contracts in UK Market

Highlights * EP&T Global Limited (EP&T) signs a multi-year agreement with a fund affiliated with MCAP Global Finance (UK) LLP, the European subsidiary ofNew York -headquartered Marathon Asset Management LP with an Annual Contract Value (ACV) ofA$0.55m and a Total Contract Value (TCV) in excess ...

2022-02-21 16:34 2105

Midea Reveals Next-Gen S8+ Robot Vacuum Cleaner to Refresh Homes this Winter

SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Midea Robozone Technology has announced the launch of the Midea S8+ intelligent auto-dust-collection robot, which liberates users' hands for up to 30 days with its automatic dust collection station. Midea Robozone Technology is a subsidiary of Midea Gr...

2022-02-21 16:00 2640

DL Holdings and YF Life Announced Strategic Partnership to Accelerate the Development of Family Office and Asset Management Business

HONG KONG, Feb. 21, 2022 /PRNewswire/ -- On 16 February 2022, DL Holdings Group Limited ("DL Holdings" or the "Company" and its subsidiaries (together, the "Group"), Stock Code: 1709)announced that it will engage in a comprehensive partnership with YF Life in the next three years. YF Life Innovat...

2022-02-21 13:23 4596

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...

2022-02-21 08:05 3915

Week's Top Stories